UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.67 billion. The enterprise value is $1.82 billion.
Market Cap | 1.67B |
Enterprise Value | 1.82B |
Important Dates
The next estimated earnings date is Wednesday, November 19, 2025, after market close.
Earnings Date | Nov 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
UTI has 54.42 million shares outstanding. The number of shares has increased by 22.52% in one year.
Current Share Class | 54.42M |
Shares Outstanding | 54.42M |
Shares Change (YoY) | +22.52% |
Shares Change (QoQ) | +0.35% |
Owned by Insiders (%) | 2.72% |
Owned by Institutions (%) | 93.54% |
Float | 52.95M |
Valuation Ratios
The trailing PE ratio is 27.01 and the forward PE ratio is 35.98.
PE Ratio | 27.01 |
Forward PE | 35.98 |
PS Ratio | 2.06 |
Forward PS | 1.88 |
PB Ratio | 5.46 |
P/TBV Ratio | 6.42 |
P/FCF Ratio | 22.39 |
P/OCF Ratio | 15.53 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.55, with an EV/FCF ratio of 24.30.
EV / Earnings | 28.78 |
EV / Sales | 2.24 |
EV / EBITDA | 15.55 |
EV / EBIT | 21.47 |
EV / FCF | 24.30 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.85.
Current Ratio | 1.00 |
Quick Ratio | 0.84 |
Debt / Equity | 0.85 |
Debt / EBITDA | 1.53 |
Debt / FCF | 3.49 |
Interest Coverage | 12.10 |
Financial Efficiency
Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 9.44%.
Return on Equity (ROE) | 23.11% |
Return on Assets (ROA) | 7.31% |
Return on Invested Capital (ROIC) | 9.44% |
Return on Capital Employed (ROCE) | 15.22% |
Revenue Per Employee | $218,792 |
Profits Per Employee | $17,055 |
Employee Count | 3,700 |
Asset Turnover | 1.12 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $20.98 million in taxes.
Income Tax | 20.98M |
Effective Tax Rate | 24.95% |
Stock Price Statistics
The stock price has increased by +85.46% in the last 52 weeks. The beta is 1.59, so UTI's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | +85.46% |
50-Day Moving Average | 28.55 |
200-Day Moving Average | 29.36 |
Relative Strength Index (RSI) | 53.17 |
Average Volume (20 Days) | 726,348 |
Short Selling Information
The latest short interest is 2.18 million, so 4.00% of the outstanding shares have been sold short.
Short Interest | 2.18M |
Short Previous Month | 2.31M |
Short % of Shares Out | 4.00% |
Short % of Float | 4.11% |
Short Ratio (days to cover) | 2.89 |
Income Statement
In the last 12 months, UTI had revenue of $809.53 million and earned $63.10 million in profits. Earnings per share was $1.14.
Revenue | 809.53M |
Gross Profit | 455.83M |
Operating Income | 84.60M |
Pretax Income | 84.09M |
Net Income | 63.10M |
EBITDA | 116.82M |
EBIT | 84.60M |
Earnings Per Share (EPS) | $1.14 |
Balance Sheet
The company has $118.32 million in cash and $261.01 million in debt, giving a net cash position of -$142.69 million or -$2.62 per share.
Cash & Cash Equivalents | 118.32M |
Total Debt | 261.01M |
Net Cash | -142.69M |
Net Cash Per Share | -$2.62 |
Equity (Book Value) | 306.79M |
Book Value Per Share | 5.64 |
Working Capital | 155,000 |
Cash Flow
In the last 12 months, operating cash flow was $107.76 million and capital expenditures -$33.03 million, giving a free cash flow of $74.73 million.
Operating Cash Flow | 107.76M |
Capital Expenditures | -33.03M |
Free Cash Flow | 74.73M |
FCF Per Share | $1.37 |
Margins
Gross margin is 56.31%, with operating and profit margins of 10.45% and 7.79%.
Gross Margin | 56.31% |
Operating Margin | 10.45% |
Pretax Margin | 10.39% |
Profit Margin | 7.79% |
EBITDA Margin | 14.43% |
EBIT Margin | 10.45% |
FCF Margin | 9.23% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.52% |
Shareholder Yield | -22.52% |
Earnings Yield | 3.77% |
FCF Yield | 4.47% |
Analyst Forecast
The average price target for UTI is $34.83, which is 13.27% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $34.83 |
Price Target Difference | 13.27% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.42 and a Piotroski F-Score of 7.
Altman Z-Score | 3.42 |
Piotroski F-Score | 7 |